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children: a community-based survey
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Abstract
Background: Zinc protoporphyrin (ZPP) has been used to screen and manage iron deficiency in individual
children, but it has also been recommended to assess population iron status. The diagnostic utility of ZPP used in
combination with haemoglobin concentration has not been evaluated in pre-school children. We aimed to a)
identify factors associated with ZPP in children aged 12–36 months; b) assess the diagnostic performance and
utility of ZPP, either alone or in combination with haemoglobin, to detect iron deficiency.
Methods: We used baseline data from 338 Kenyan children enrolled in a community-based randomised trial. To
identify factors related to ZZP measured in whole blood or erythrocytes, we used bivariate and multiple linear
regression analysis. To assess diagnostic performance, we excluded children with elevated plasma concentrations
of C-reactive protein or α1-acid glycoprotein, and with Plasmodium infection, and we analysed receiver operating
characteristics (ROC) curves, with iron deficiency defined as plasma ferritin concentration < 12 μg/L. We also
developed models to assess the diagnostic utility of ZPP and haemoglobin concentration when used to screen for
iron deficiency.
Results: Whole blood ZPP and erythrocyte ZPP were independently associated with haemoglobin concentration,
Plasmodium infection and plasma concentrations of soluble transferrin receptor, ferritin, and C-reactive protein.
In children without inflammation or Plasmodium infection, the prevalence of true iron deficiency was 32.1%,
compared to prevalence of 97.5% and 95.1% when assessed by whole blood ZPP and erythrocyte ZPP with
conventional cut-off points (70 μmol/mol and 40 μmol/mol haem, respectively). Addition of whole blood ZPP or
erythrocyte ZPP to haemoglobin concentration increased the area-under-the-ROC-curve (84.0%, p = 0.003, and 84.
2%, p = 0.001, respectively, versus 62.7%). A diagnostic rule (0.038689 [haemoglobin concentration, g/L] + 0.00694
[whole blood ZPP, μmol/mol haem] >5.93120) correctly ruled out iron deficiency in 37.4%–53.7% of children
screened, depending on the true prevalence, with both specificity and negative predictive value ≥90%.
Conclusions: In young children, whole blood ZPP and erythrocyte ZPP have added diagnostic value in detecting
iron deficiency compared to haemoglobin concentration alone. A single diagnostic score based on haemoglobin
concentration and whole blood ZPP can rule out iron deficiency in a substantial proportion of children screened.
Trial registration: ClinicalTrials.gov NCT02073149 (25 February 2014).
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Background
Zinc protoporphyrin (ZPP) is formed in erythrocytes
when the iron supply for erythropoiesis is less than
required, or when iron utilization is impaired. In such
conditions of iron-deficient erythropoiesis, protoporphy-
rin IX, the immediate precursor of haem, incorporates
an atom of zinc rather than iron, resulting in the forma-
tion of ZPP instead of haem. Thus, depleted iron stores
or a decrease in circulating iron in the bone marrow lead
to elevated ZPP concentrations in whole blood or eryth-
rocytes [1, 2].
ZPP can be determined rapidly and at low assay cost
by haematofluorometer. It has been used to screen and
manage iron deficiency in individual children, but it has
also been a recommended marker to assess population
iron status in cross-sectional studies, together with
haemoglobin concentration [1, 3].
One possible application concerns the use of a single
score that captures the diagnostic information of both
whole blood ZPP and haemoglobin concentration in a
screen-and-treat approach to manage iron deficiency in
preschool children. Such diagnostic utility has not been
assessed in pre-school children. We found earlier,
however, that both whole blood ZPP and erythrocyte
ZPP have little diagnostic utility as a screening marker
to manage iron deficiency in pregnant women, whether
used as single tests or combined with haemoglobin con-
centration [4].
The present study aimed to identify factors associated
with ZPP measured in whole blood or erythrocytes from
preschool children. We also assessed the diagnostic
performance and utility of ZPP, either alone or in com-
bination with haemoglobin concentration, in detecting
iron deficiency defined as plasma ferritin concentra-
tion < 12 μg/L in children without inflammation or
Plasmodium infection.
Methods
Study setting and population
The present study made use of samples that were
collected at baseline in a randomised placebo-controlled
trial to show non-inferiority of home fortification with
3 mg iron as NaFeEDTA compared with 12.5 mg iron as
encapsulated ferrous fumarate. The main results of this
trial will be reported elsewhere [5]. The study was con-
ducted in children aged 12–36 months from January–
December 2014 in Kisumu-West District, Kenya, an area
that is located at around 1350 m above sea level. To
recruit the children, community health workers com-
piled a list of parents with children within the eligible
age range in a predefined study area and invited par-
ents to bring all of them for screening to the research
clinic, where parents were asked to sign an informed
consent form.
Collection of data and samples
We determined weight and height using Salter Scale
(UNICEF, catalogue 0145555, Copenhagen, Denmark)
and height/recumbent length boards (UNICEF, catalogue
0114500, Copenhagen, Denmark) within 100 g and
1 mm, respectively. Phlebotomists collected 4 mL
venous blood in tubes containing Li-heparin. An aliquot
of blood was centrifuged, plasma was transferred to a
microtube, centrifuged, and stored immediately in liquid
nitrogen (−196 °C). The erythrocyte sediment was
washed and centrifuged three times with isotonic
phosphate-buffered saline. We assessed haemoglobin
concentration (HemoCue 301, Ängelholm, Sweden) in
duplicate, and zinc protoporphyrin: haem ratio (AVIV
haematofluorometer, model 206D, Lakewood NJ, USA)
in whole blood and in erythrocytes, each in triplicate.
For quality control of the haematofluorometer, we used
erythrocyte controls for low, medium and high ZPP
values from the manufacturer (Aviv) and as per manu-
facturer’s instructions. Measurements were within the
acceptable range throughout the study.
ZPP in washed erythrocytes is considered a more valid
measure of iron-deficient erythropoiesis when compared
to ZPP in whole blood because the washing process
removes substances dissolved in plasma such as bilirubin
and riboflavin that can fluoresce at a wavelength similar
to that of ZPP.
We used two rapid diagnostic tests to detect Plasmo-
dium antigenaemia. CareStart G0151 (AccessBio, USA;
http://www.accessbio.net/) can detect lactate hydrogenase
(pLDH) produced by either P. falciparum or Plasmodium
species other than P. falciparum (i.e. P. ovale, P. malariae
or P. vivax). CareStart G0171 can detect histidine-rich
protein-2 (HRP2), which is produced exclusively by P.
falciparum.
Plasma iron indicators (concentrations of ferritin and
soluble transferrin receptor), inflammation indicators
(concentrations of C-reactive protein and α-1-acid glyco-
protein) and other nutritional markers (concentrations
of albumin and vitamin B12) were measured on an
Abbott Architect C16000 and i2000 SR analyser at
Meander Medical Centre, Amersfoort, The Netherlands,
with reagents from and as per instructions of the
manufacturer.
Eligibility criteria
After data and blood samples were collected but before
randomisation to intervention, children were given
pre-medication (3-day courses of dihydroartemisinin-
piperaquine and albendazole; a single dose of prazi-
quantel). Children were eligible for enrolment in the
trial and the present study if: aged 12–36 months,
resident in the study area; parental consent form
signed by both parents; not acutely sick or febrile
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(axillary temperature ≥ 37.5 °C) at the time of recruit-
ment; absence of reported or suspected major sys-
temic disorder (e.g. HIV infection, sickle cell disease);
no use of antiretroviral drugs against HIV, rifampicin,
carbamazepine, phenytoin or phenobarbital and no
twin sibling. Children were excluded if: haemoglobin
concentration < 70 g/L (for ethical reasons, because
the trial had a placebo arm); severely wasted (weight-for-
height z-score < −3 SD); known allergy to dihydro
artemisinin-piperaquine, benzimidazole or praziquantel;
parent-reported history of using antihelminthic drugs in
the 1-month period before the screening date; not at risk
of malaria (e.g. children who received chemoprophylaxis
against malaria because of HIV infection or sickle cell dis-
ease); they received their first dose of dihydroartemisinin-
piperaquine at the research clinic and did not complete
the prescribed second and third doses at home.
Sample size determination
We included all children enrolled in the trial in the
present study. Our sample size calculations were based
on our primary aim to show non-inferiority of the
haemoglobin concentration response to home fortifica-
tion with 3 mg iron as NaFeEDTA compared with
12.5 mg iron as ferrous fumarate intention. Because this
aim is irrelevant to the present study, these calculations
are not reported here, although they are available
elsewhere [5].
Statistical analysis
Definitions
Anthropometric indices were calculated by comparing
measurements with the standards WHO Growth
Standards [6]. For whole blood and erythrocyte ZPP, we
used a cut-off value of 70 μmol/mol haem (2.7 μg/g
haemoglobin), corresponding to the 95% upper limit of
the reference values for women and children participating
in the US National Health and Nutrition Examination
Survey (NHANES) II, from which individuals with an-
aemia, low transferrin saturation and elevated blood lead
concentrations had been excluded [1–3]. For erythrocyte
ZPP, we also used a cut-off point of 40 μmol/mol haem,
which is based on several small studies comparing iron-
deficient and iron-replete individuals [7].
We defined iron deficiency as the absence or near-
absence of storage iron, indicated by plasma ferritin
concentration < 12 μg/L [8]. Because this definition is
recommended by WHO to measure population iron
status except where inflammation is prevalent [2], we
considered it to be valid only in children without inflam-
mation, Plasmodium infection, or HIV infection. In
addition, we used the following definitions: anaemia:
haemoglobin concentration < 108 g/L (i.e. 110 g/L refer-
ence range for children aged 6–59 months, at sea level,
minus 2 g/L adjustment for an altitude at 1000–1500 m
above sea level) [9]; inflammation: plasma concentra-
tions of C-reactive protein concentration > 5 mg/L [10]
and/or α1-acid glycoprotein concentration > 1 g/L [11];
being stunted or wasted: height-for-age or weight-for-
height z-score < −2 SD; [6] P. falciparum infection: pres-
ence in blood of HRP2 or P. falciparum-specific pLDH;
any Plasmodium infection: presence of HRP2 or pLDH
specific to either P. falciparum or human Plasmodium
species other than P. falciparum; low vitamin B12 status:
plasma vitamin B12 concentration < 150 pmol/L.
Description of the study population
We calculated prevalence values for binary variables,
means with corresponding SDs for variables with an
approximately normal distribution, and quartiles for
continuous variables that were not normally distributed.
Because some of the plasma markers used (ferritin,
albumin, vitamin B12) can act as acute phase reactants
we also described these characteristics in children with-
out inflammation or Plasmodium infection.
Factors associated with ZPP
We explored associations between ZPP and personal
characteristics (age, sex), inflammation markers, iron
markers, Plasmodium infection and other plasma
markers (albumin and vitamin B12 concentrations).
Groups were compared assuming t-distributions of ZPP
values that were normalised by log-transformation.
Exponentiation of results yielded group differences that
were expressed as relative differences.
We inspected scatterplots and used simple linear
regression analysis to assess associations between ZPP
(log-transformed) and explanatory variables with
continuous outcomes. Some explanatory factors were
untransformed, with the implicit assumption that ZPP
values can increase or decrease exponentially with an
absolute increment in the explanatory variable; in other
cases, log-transformation of the explanatory factor
yielded a better model fit, indicating that ZPP values and
explanatory variables change at rates that are propor-
tional to their current values. In such cases, variation in
the independent variable was expressed as geometric
standard deviation, i.e. a dimensionless, multiplicative
factor such that dividing or multiplication of the geo-
metric mean by this ratio indicates a variation that is
equivalent to subtraction or addition of one standard
deviation on a log-transformed scale [12].
We subsequently used multiple linear regression
analyses to identify factors that were independently
associated with ZPP. Given a linear association between
continuous variables, dichotomisation generally results
in loss of statistical precision [13]. Thus we preferred to
use continuous variables that were shown to be linearly
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associated with ZPP in the bivariate analyses. Our
analysis started with a full model that included haemo-
globin concentration, Plasmodium infection, and plasma
concentrations of ferritin, soluble transferrin receptor,
C-reactive protein, α1-acid glycoprotein, albumin, vita-
min B12, sex (binary) and age class (binary). All plasma
markers except albumin and vitamin B12 were log-
transformed. Factors were manually eliminated using a
backward elimination process with a removal criterion
of p > 0.05.
Diagnostic performance of ZPP to detect iron deficiency
This part of the analysis was restricted to children
without inflammation (i.e. plasma concentrations of
C-reactive protein <5 mg/L and/or α1-acid glycopro-
tein <1 g/L) and without Plasmodium infection. We
used logistic discriminant analysis to model the prob-
ability of iron deficiency as a function of continuous
explanatory variables, either alone or combined.
We used the pROC package [14] within R vs. 3.2.0
(www.r-project.org) to produce and analyse receiver op-
erating characteristics (ROC) curves, with comparison of
areas-under-the-curve (AUCs) by DeLong’s test for
paired curves. Partial AUCs were computed with a
correction to achieve a maximal value of 1.0 and a non-
discriminant value of 0.5, whatever the range of spe-
cificity or sensitivity values. Confidence intervals of
estimates for partial areas-under-the-curve (pAUCs)
were computed by stratified bootstrapping with
10,000 replicates.
Diagnostic utility of ZPP to estimate prevalence of iron
deficiency
First, we assessed the diagnostic performance of ZPP
to estimate the prevalence of iron deficiency, using
two commonly used cut-off points for ZPP, namely
whole blood ZPP >70 μmol/mol haem and erythro-
cyte ZPP >40 μmol/mol haem (see preceding para-
graphs). We used Wilson’s method to calculate
confidence intervals around proportions [15, 16]; for
sensitivity and specificity, and for the pair of predict-
ive values, we calculated 97.5% univariate CIs. The
cross-product of these univariate CIs, considered to-
gether, form a joint 95% confidence region for both
population parameters [17].
Second, as an example, we used our data to explore
the utility of using the combination of haemoglobin
concentration and ZPP to screen for iron deficiency
(Additional file 1), with cut-points chosen to ensure a
high sensitivity so that most cases are detected, at the
cost of false positives that could be eliminated by further
diagnostic tests. Children can be excluded from further
testing if negative test results correctly identify children
without iron deficiency in the vast majority of cases.
Such a strategy may be desirable in community-based
surveys with relatively low prevalence of iron deficiency,
but also in medical practice with higher prevalence
values (because of self-selection). Thus we estimated the
proportion of children who could be eliminated from
further testing in settings with a prevalence range for
iron deficiency of 0%–50%, which probably covers the
vast majority of community settings, with arbitrarily
selected sensitivity values and negative predictive
values of >90%. Because of its ease of measurement,
we limited this assessment with ZPP being measured
in whole blood.
Results
We enrolled 338 children into the study.
Description of the study population
The prevalence of iron deficiency, measured in children
without inflammation or Plasmodium infection, was
32.1%; when measured in all children (Table 1), this
value was 17.1%. Whole blood ZPP > 70 μmol/mol haem
occurred in 97.9% and erythrocyte ZPP > 40 μmol/mol
occurred in 96.7% of children. The prevalence of
anaemia was 55.6%, but there were virtually no children
with low vitamin B12 status. Inflammation, assessed by
plasma concentrations of C-reactive protein and α1-acid
glycoprotein, occurred in 66.9% of children, and was
mostly mild. Of 226 children with inflammation, 98
(43.4%) had elevated concentrations of α1-acid glycopro-
tein with normal C-reactive protein concentrations, 11
(4.9%) had elevated C-reactive protein concentrations
with normal concentrations of α1-acid glycoprotein, and
117 (51.8%) had elevated concentrations of both
markers. Of children who carried Plasmodium parasites
(36.4% = 123/338), only 1 was infected with Plasmodium
species other than P. falciparum.
Factors associated with ZPP: Crude analysis
In bivariate analysis, both whole blood and erythro-
cyte ZPP were strongly elevated in iron deficiency,
anaemia and Plasmodium infection; they declined
with increasing haemoglobin and plasma ferritin
concentrations; and they increased with plasma trans-
ferrin receptor concentration (Table 2). Whole blood
ZPP was also associated with increased plasma
concentrations of α1-acid glycoprotein and C-reactive
protein concentration; a higher prevalence of inflam-
mation as defined by α1-acid glycoprotein >1 g/L;
decreased plasma albumin concentration, and in-
creased plasma vitamin B12 concentration. Although
erythrocyte ZPP was reduced in children aged 24–
36 months and, seemed higher in boys than in girls,
there was no evidence that it was associated with
inflammation, however defined, or with either of the
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two plasma inflammation markers. We found no
evidence that ZPP, whether measured in whole blood
or erythrocytes, was associated with z-scores for
height-for-age or weight-for-height, or with being
stunted or wasted.
Factors associated with ZPP: Multiple linear regression
analysis
In multivariate analysis, there was no evidence that ZPP,
whether measured in whole blood or erythrocytes, was
associated with plasma concentrations of α1-acid
Table 1 Characteristics of the study population
All children Children without inflammation
or Plasmodium infection
n 338 84
Age
12–23.99 months 53.6% (181) 54.8% (46)
24–36 months 46.4% (157) 45.2% (38)
Sex, male 55.0% (186) 47.6% (40)
Height-for-age z-score, SD −1.33 (1.4) −0.91 (1.5)
Stunted (height-for-age z-score < −2 SD) 30.2% (102) 14.3% (12)
Weight-for-height z-score, SD −0.14 (1.0) −0.15 (0.97)
Wasted (weight-for-age z-score < −2 SD) 3.0% (10) 2.4% (2)
Whole blood ZPP, μmol/mol haem 181 [124–282] 131 [98–239]
Whole blood ZPP > 70 μmol/mol haem 97.9% (331) 97.6% (82)
Erythrocyte ZPP, μmol/mol haem 142 [86–246] 117 [69–215]
Erythrocyte ZPP > 70 μmol/mol haem 83.1% (281) 72.6% (61)
Erythrocyte ZPP > 40 μmol/mol haem 96.7% (327) 95.2% (80)
Haemoglobin concentration, g/L 105.0 (13.2) 111.7 (10.0)
Anaemia (haemoglobin concentration < 108 g/L) 55.6% (188) 34.5% (29)
Plasma ferritin concentration, μg/L 35.3 [17.1–67.2]a 17.3 [10.3–28.8]b
Iron statusc
Deficient 17.1% (57/333) 32.1% (27/81)
Replete 23.1% (77/333) 64.3% (54/81)
Uncertain 59.8% (199/333) Not applicable
Plasma sTfR concentration, mg/L 2.43 [1.84–3.30] 2.11 [1.50–2.94]
Plasma albumin concentration, g/L 34.8 (3.9) 37.4 (2.2)
Plasma vitamin B12 concentration, pmol/L 400 [307–559]
d 356 [283–452]e
Plasma vitamin B12 concentration < 150 pmol/L 1.2% (4/332) 1.2% (1/80)
Plasma CRP concentration, mg/L 2.9 [0.8–9.2] Not applicable
Plasma AGP concentration, g/L 1.16 [0.9–1.55] Not applicable
Inflammation
Plasma CRP concentration > 5 mg/L 37.9% (128) Not applicable
Plasma AGP concentration > 1.0 g/L 63.6% (215) Not applicable
Plasma CRP concentration > 5 mg/L, or plasma AGP concentration > 1.0 g/L 66.9% (226) Not applicable
Plasmodium infection
P. falciparum 36.1% (122) Not applicable
Plasmodium spp. other than P. falciparum 0.3% (1) Not applicable
Missing 0.9% (3) Not applicable
Values indicate mean (SD), median [25th and 75th percentile] or % (n)
AGP α1-acid glycoprotein, CRP C-reactive protein, sTfR soluble transferrin receptor, ZPP zinc protoporphyrin
Missing values, due to insufficient plasma volumes for analysis, resulted in an = 333, bn = 81; cDeficient: plasma ferritin concentration < 12 μg/L, regardless of the
presence or absence of inflammation; replete: plasma ferritin concentration ≥ 12 μg/L, in the absence of inflammation; uncertain: plasma ferritin
concentration ≥ 12 μg/L, in the presence of inflammation defined as plasma concentrations of CRP > 5 mg/L or AGP > 1.0 g/L. Missing values, due to insufficient
plasma volumes for analysis, resulted in dn = 332 and en = 80
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glycoprotein and vitamin B12, or with sex or age class.
Thus, these factors were eliminated from the models
shown in Table 3.
Whole blood ZPP was independently associated with
decreased concentrations of haemoglobin and ferritin
and with increased plasma concentrations of transferrin
Table 2 Factors associated with ZPP-haem ratio measured in whole blood or erythrocytes, crude analysisa
Factor Number Whole blood ZPP-haem ratio Erythrocyte ZPP-haem ratio
Geometric mean Δb (95% CI) Geometric mean Δb (95% CI)
Age
12–23.99 months 162 199 Ref 163 Ref
24–36 months 176 178 −10.8% (−21.2% to 0.9%) 134 −18.1% (−4.3% to −29.9%)
Sex
Girls 152 179 Ref 135 Ref
Boys 186 195 9.4% (−3.4% to 23.8%) 158 16.4% (−0.5% to 36.1%)
Inflammation (CRP concentration > 5 mg/L)
No 210 180 Ref 144 Ref
Yes 128 201 11.4% (−1.9% to 26.5%) 153 6.6% (−9.3% to 25.4%)
Inflammation (AGP concentration > 1 g/L)
No 123 166 Ref 136 Ref
Yes 215 201 21.4% (7.0% to 37.9%) 154 13.3% (−3.7% to 33.3%)
Inflammation (CRP concentration > 5 mg/L or AGP concentration > 1 g/L)
No 112 166 Ref 137 Ref
Yes 226 199 20.0% (5.4% to 36.7%) 153 11.4% (−5.6% to 31.6%)
Iron deficiency (ferritin concentration < 12 μg/L)
No 276 173 Ref 132 Ref
Yes 57 278 60.4% (36.9% to 87.8%) 255 93.6% (58.8% to 136.0%)
Anaemia
No 150 135 Ref 103 Ref
Yes 188 244 81.4% (63.3% to 101.4%) 195 89.1% (64.3% to 117.5%)
Plasmodium infection, any species
No 212 167 Ref 131 Ref
Yes 123 230 37.5% (21.5% to 55.6%) 180 38.1% (18.6% to 60.8%)
Plasma ferritin concentration,
5.11-fold changed, e
−16.7% (−24.6% to −7.9%) −18.1% (−24.1% to −11.6%)
Plasma sTfR concentration,
1.43-fold changed
38.3% (34.0% to 42.7.0%) 66.8% (57.7% to 76.4%)
Plasma CRP concentration,
2.72-fold changed
3.5% (0.8% to 6.2%) 6.8% (−1.2% to 15.5%)
Plasma AGP concentration,
1.60-fold changed
23.7% (10.0% to 39.1%) 7.1% (−1.0% to 15.8%)
Haemoglobin concentration,
change by 13.2 g/Lf, g
−29.8% (−33.1% to −26.2%) −31.5% (−35.9% to −26.7%)
Plasma albumin concentration,
change by 3.9 g/Lf
−7.0% (−12.5% to −1.1%) −1.4% (−8.9% to 6.7%)
Plasma vitamin B12 concentration,
change by 213 pmol/Lf
7.0% (0.6% to 13.9%) 6.1% (−2.0% to 14.8%)
AGP α1-acid glycoprotein, CRP C-reactive protein, GSD geometric standard deviation, Ref reference, SD standard deviation, sTfR soluble transferrin receptor,
ZPP zinc protoporphyrin
aZPP values were normalised by log-transformation; exponentiation of results yielded associations being expressed as relative differences; bDifference; cBased on
HRP2- and pLDH-based dipstick test results; dCorresponding to 1 geometric standard deviation; eFor example, a 5.11-fold increase in plasma ferritin concentration,
which corresponds to a variation that is equivalent to addition of 1 SD on a log-transformed scale, is associated with a reduction in the whole blood ZPP-haem
ratio by 16.7%; fCorresponding to 1 SD; gFor example, an increase in haemoglobin concentration by 13.2 g/L, which corresponds to an increase by 1 SD, is
associated with a reduction in the whole blood ZPP-haem ratio by 29.8%
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receptor and C-reactive protein (Table 3). Of all bio-
chemical markers, plasma transferrin receptor concen-
tration showed the strongest association with whole
blood and erythrocyte ZPP. Similar results were found
with erythrocyte ZPP as dependent variable. Plasmo-
dium infection was associated with elevated whole blood
ZPP, and an even more pronounced elevation in erythro-
cyte ZPP values. There was a mild association between
plasma albumin concentration and erythrocyte ZPP, but
retention of this factor in the model for whole blood
ZPP did not appreciably change the magnitude of the
association for other factors.
Diagnostic performance of ZPP to detect iron deficiency
ROC curve analysis showed that whole blood and
erythrocyte ZPP had similar diagnostic performance
(AUC values: 79.1% and 81.2%, respectively; p = 0.36) in
detecting iron deficiency, but either marker performed
better than haemoglobin concentration (AUC: 62.7%)
(Fig. 1a; Table in Fig. 1). The diagnostic accuracy was
further improved by combining either whole blood or
erythrocyte ZPP with haemoglobin (Fig. 1b, p=0.003;
and Fig. 1c, p=0.001, respectively).
Overall, there was no evidence that the diagnostic accur-
acy differed between the combination of haemoglobin
concentration with erythrocyte ZPP and the combination
of haemoglobin concentration with whole blood ZPP
(AUCs: 84.2% versus 84.0%; p = 0.91). The ROCs for these
markers crossed (Fig. 1d) at a sensitivity of 81.5%, corre-
sponding to 0.07195[Hb] + 0.01449[ZZPwhole] = 10.39334
(where Hb and ZPPwhole indicate haemoglobin concentra-
tion in g/L and whole blood ZPP:haem ratio in μmol/mol,
respectively; in this equation, parameter estimates are
shown with 5 decimals to avoid misclassification due to
multiplication of rounding errors). At all sensitivity values
above this cut-off (Fig. 1d, red rectangle), the diag-
nostic accuracy of the combination of erythrocyte
ZPP with haemoglobin concentration was superior to
the combination of whole blood ZPP with haemoglo-
bin concentration (corrected pAUCs: 76.3% versus
70.4%, p = 0.04).
Diagnostic utility of ZPP
When whole blood ZPP was considered without add-
itional markers to detect iron deficiency, a conventional
threshold of 70 μmol/mol haem resulted in the following
estimates (Table 4): sensitivity: 100%; specificity: 3.7%,
positive predictive value: 34.2%; prevalence: 97.5% (as
compared to a ‘true’ prevalence of 32.1%; Table 1).
Corresponding values for an erythrocyte ZPP threshold
of 40 μmol/mol haem were: 100%, 7.4%, 35.1% and
95.1%.
Within a prevalence range of iron deficiency of <14.1%,
a diagnostic rule of haemoglobin concentration > 122 g/L
would rule out iron deficiency in 14.1%–14.8% of children
tested, depending on the actual prevalence, with both
sensitivity and negative predictive value >90% (Fig. 2).
Similarly, within a prevalence range of iron deficiency
of <28.6%, whole blood ZPP > 99 μmol/mol haem
would rule out iron deficiency in 28.6%–36% of chil-
dren tested; and within a prevalence range of 37.4%,
0.038689 [Hb] + 0.00694 [whole blood ZPP] > 5.93120
would rule out iron deficiency in 37.4%–53.7% of
children. At all prevalence values exceeding these
ranges, these diagnostic tests would not be able to rule
out children with the predefined diagnostic criteria (i.e.
both sensitivity and negative predictive value should be
90%), and all children would need to undergo further
diagnostic work-up using more advanced tests.
Discussion
In our population, virtually all children had whole blood
ZPP values exceeding conventional cut-off points of
70 μmol/mol haem, resulting in very low specificity and
gross overestimates of the ‘true’ prevalence of iron
deficiency of 32.1%, whether assessed in the overall
Table 3 Factors associated with ZPP-haem ratio measured in whole blood or erythrocytes, multiple linear regression analysisa
Whole blood ZPP-haem
ratio (model 1)
Whole blood ZPP-haem
ratio (model 2)
Erythrocyte ZPP-haem ratio
Δb (95% CI) Δb (95% CI) Δb (95% CI)
Plasma ferritin concentration, 5.11-fold changec −10.1% (−14.3% to −5.6%) −9.6% (−14.0% to −4.9%) −15.5% (−21.1% to −9.5%)
Plasma sTfR concentration, 1.43-fold changec 34.8% (28.3% to 41.7%) 34.9% (28.3% to 41.8%) 45.3% (35.7% to 55.6%)
Plasma CRP concentration, 2.72-fold changec 5.0% (0.1% to 10.0%) 5.4% (0.4% to 10.5%) 9.8% (2.8% to 17.2%)
Haemoglobin concentration, change by 13.2 g/Ld −13.9% (−18.3% to −9.4%) −14.9% (−19.4% to −10.1%) −14.5% (−20.7% to −7.9%)
Plasmodium infection, any speciese 17.3% (7.8% to 27.7%) 16.8% (7.4% to 27.2%) 93.3% (23.8% to 202.0%)
Plasma albumin concentration, change by 3.9 g/Ld ― (eliminated) 3.0% (−1.7% to 8.0%) 2.2% (0.5% to 4.0%)
CRP C-reactive protein, sTfR soluble transferrin receptor, ZPP zinc protoporphyrin
aZPP values were normalised by log-transformation; exponentiation of results yielded associations being expressed as relative differences. Plasma concentrations
of α1-acid glycoprotein (log-transformed), vitamin B12 (log-transformed), sex (binary) and age class (binary) were eliminated from all models through a manual
stepwise backward elimination process with an removal criterion of p > 0.05; bDifference; cCorresponding to 1 geometric standard deviation; dCorresponding to 1
SD; eBased on HRP2- and pLDH-based dipstick test results
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population or when restricted to those without inflam-
mation and without Plasmodium infection. A similar
problem was noted with erythrocyte ZPP > 40 μmol/mol
haem. Both whole blood ZPP and erythrocyte ZPP were
independently associated with Plasmodium infection and
plasma C-reactive protein concentration. ZPP, whether
measured in whole blood or erythrocytes, yielded higher
diagnostic accuracy in detecting iron deficiency than
haemoglobin concentration alone, and also improved
this diagnostic accuracy when used in combination with
haemoglobin concentration. When applied in a screen-
and-treat strategy to control iron deficiency in paediatric
populations with a prevalence of iron deficiency of
<37.4% (which covers most settings in developing
countries), our data suggest that a diagnostic rule of
0.038689 [Hb] + 0.00694 [whole blood ZPP] > 5.93120
Fig. 1 Ability of zinc protoporphyrin-haem ratio, either alone or in combination with haemoglobin concentration, to discriminate between children
with and without iron deficiency. Panel a: Receiver operating characteristics (ROC) curves for various blood markers, used alone, to discriminate
between iron-deficient and iron-replete children. Panel b: As in Panel a, with haemoglobin concentration and whole blood ZPP, alone and in
combination. Panel c: As in Panel a, with haemoglobin concentration and erythrocyte ZPP, alone and in combination. Panel d: As in Panel a, with
combined haemoglobin concentration and whole blood ZPP, versus combined haemoglobin concentration and erythrocyte ZPP. Hb: haemoglobin
concentration. Grey diagonal lines in ROC curves indicate a ‘worst’ possible test, which has no discriminatory value and an area-under-the-curve (AUC)
of 0.5. An ideal marker would have a curve that runs from the lower-left via the upper-left to the upper-right corner, yielding an AUC of 1.0
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can correctly identify 90% of children with iron
deficiency, and correctly rule out iron deficiency in
37.4%–53.7% of children who are tested, depending on
the true prevalence.
Lead poisoning can cause elevated ZPP values, but
lead exposure is presumably low in rural African
children. Thus, the high ZPP values found in this study
population may have been due to a combination of
factors causing an inadequate supply of iron to erythro-
blasts (iron deficiency, inflammation) and increased
erythropoiesis (haemolysis due to Plasmodium infection
and possibly selected hereditary disorders such as
glucose-6-phosphate dehydrogenase deficiency, sickle
cell and α+-thalassaemia). In a previous trial in the same
area as the present study, α+-thalassaemia occurred in
48.8% of pregnant women (heterozygotes: 41.3%; homo-
zygotes: 7.5%), but there was no evidence that it was as-
sociated with ZPP [4]. In a nearby area, the prevalence
of sickle cell trait and sickle cell disease in preschool
children was 17.1% and 1.6%, respectively; genotypes in-
dicating G6PD deficiency occurred in 8.2% of males and
6.8% of children overall, whilst the prevalence of hapto-
globin 2–2 genotype was 20.4% [17, 18] A study in
Gambian children aged 2–6 years, however, failed to
find an association between haptoglobin genotype and
ZPP [19].
We found a particularly strong relationship between
ZPP, whether measured in whole blood or erythrocytes,
and plasma transferrin receptor concentration. This is
not surprising because both are markers for iron-
deficient erythropoiesis. Consistent with our data, ZPP is
known to be increased in iron deficiency, inflammation
and other causes of an inadequate iron supply to eryth-
roblasts. The increase in whole blood ZPP that was
associated with Plasmodium infection may be due in
part to the formation of bilirubin and other haemoglobin
breakdown products in plasma that result from haem-
olysis and that fluoresce in the same wavelength range
as protoporphyrins. Plasmodium infection was also asso-
ciated with an even larger increase in erythrocyte ZPP,
independently of inflammation. This was unexpected be-
cause erythrocytes lack plasma constituents, which are
removed by washing. A possible explanation is that
haemolysis-induced increase in erythropoietin activity
under influence of Plasmodium infection drives up the
demand for iron in the erythron. We have not been able
to find previous reports of an association between
erythrocyte ZPP and plasma albumin concentration,
which could be a spurious finding.
One limitation of our study is the difficulty of measuring
iron status in the presence of inflammation. Throughout
the remainder of this discussion, it should be noted that
we assessed the diagnostic performance and ZPP in
children without inflammation and without Plasmodium
infection, because plasma ferritin concentration can be el-
evated in the presence of infection-induced inflammation
independently of iron status. We used this approach in
favour of other biomarkers and approaches that have been
proposed.
In one method [20, 21], fixed correction factors for
serum ferritin concentrations are computed based on
geometric mean values in groups that are defined by
cross-classification of individuals by two inflammation
markers (serum concentrations of C-reactive protein
>5 g/L and α1-acid glycoprotein >1.0 g/L). The resulting
ratios in geometric mean values are used to adjust indi-
vidual values, and deficiency is determined on the basis
of these adjusted values. This method has the disadvan-
tages, however, that it is not validated using a reference
standard, its validity depends on untested and perhaps
invalid assumptions, and it does not take into account
likely between-person variability in the response of
Table 4 Diagnostic performance of zinc protoporphyrin-haem ratio, with dichotomised test results, to detect iron deficiency
n/n Estimate (CI)
Whole blood ZPP > 70 μmol/mol haem
Sensitivity 27/27 100.0% (84.4%–100.0%)a
Specificity 2/54 3.7% (0.9%–14.4%)a
Positive predictive value 27/79 34.2% (23.5%–46.7%)a
Negative predictive value 2/2 100.0% (28.6%–100.0%)a
Prevalence 79/81 97.5% (91.4%–99.3%)b
Erythrocyte ZPP > 40 μmol/mol haem
Sensitivity 27/27 100.0% (84.4%–100.0%)a
Specificity 4/50 7.4% (2.6%–19.5%)a
Positive predictive value 27/77 35.1% (24.2%–47.8%)a
Negative predictive value 4/4 100.0% (44.4%–100.0%)a
Prevalence 77/81 95.1% (88.0%–98.1%)b
a97.5% CI; b95% CI
Teshome et al. BMC Hematology  (2017) 17:11 Page 9 of 12
Fig. 2 Application of a diagnostic strategy to rule out iron deficiency. [Hb]: haemoglobin concentration, expressed in g/L; [whole blood ZPP]:
whole blood ZPP content, expressed in μmol/mol haem. The diagnostic strategy in a screen-and-treat survey is based on two criteria: a) the
probability of correctly diagnosing iron deficiency should exceed 90%; and b) iron deficiency can be ruled out if the probability of a negative test
result being correct (negative predictive value) exceeds 90%. To meet the first requirement, a cut-off point for each diagnostic test result (top) is
selected to yield a sensitivity of 90%; the corresponding specificity value is obtained from the ROC curves (Fig. 1). For haemoglobin concentration
and whole blood ZPP, the cut-off points were 122 g/L and 99 μmol/mol haem; the corresponding specificity values were 14.8% and 36.0%,
respectively. When these markers were combined in a single diagnostic rule, 0.038689 [Hb] + 0.00694 [whole blood ZPP] > 5.93120 had a
specificity of 53.7%. The negative predictive value (top panels, blue lines) depends on sensitivity and specificity values thus fixed, and the
prevalence of iron deficiency. The second diagnostic criterion, i.e. the negative predictive value should exceed 90%, applies only within a limited
prevalence range (top panels, red rectangle); at prevalence values exceeding this range, the negative predictive value will be below 90% and iron
deficiency cannot be ruled out with diagnostic test applied (top). The percentage of children with a negative test result declines linearly with the
prevalence of iron deficiency (middle panels, blue lines). The percentage of children for whom iron deficiency can be ruled out (middle panels,
Y-intercepts of red rectangles) depends on the prevalence range in which the negative predictive value exceeds 90% (top panels, red rectangles).
With fixed sensitivity and specificity values, the positive predictive value (bottom panels, blue lines) increase monotonically with the prevalence of
iron deficiency. Within the prevalence range in which the negative predictive value exceeds 90% (top panels, red rectangles), the highest
positive predictive value is 54% (for combined use of haemoglobin concentration and whole blood ZPP), indicating that additional tests
(i.e. other than haemoglobin concentration and whole blood ZPP) are required to accurately determine iron status. For example, haemoglobin
concentration > 122 g/L (left panels) has 90% sensitivity of detecting iron deficiency; at a true prevalence of iron deficiency <14.1%, a negative test
result obtained with this decision rules out iron deficiency with a probability of 90% (upper left panel, red rectangle). Depending on the true
prevalence of iron deficiency, such a cut-off for haemoglobin concentration would result in iron deficiency being ruled out in 14.1%–14.8% of children
who are tested (middle left panel, red rectangle). Similarly, within a prevalence range < 28.6%, whole blood ZPP > 99 μmol/mol haem rules out iron
deficiency in 28.6%–36% of children tested. Within a prevalence range of <37.4%, 0.038689 [Hb] + 0.00694 [whole blood ZPP] > 5.93120 rules out iron
deficiency in 37.4%–53.7% of children
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ferritin concentration to inflammation. Another limita-
tion is the possibility that plasma ferritin concentration
is possibly elevated at levels of inflammatory markers
within the normal range (serum C-reactive protein
concentration < 5 mg/L or plasma α1-acid glycoprotein
concentration < 1.0 g/L). This limitation also applies, of
course, to the restriction method used in the analysis of
the present paper.
Recently, it has been proposed to adjust values using
regression analysis [12]. Although this approach offers
several theoretical advantages, its validity remains to be
investigated by comparison with a reference standard.
The ratio of concentrations of soluble transferrin recep-
tor/log ferritin has been suggested as a marker of body
iron content but its use to detect iron deficiency remains
problematic for reasons discussed elsewhere [4].
Our results clearly show that, in the absence of inflam-
mation or Plasmodium infection, ZPP has added diagnos-
tic value in detecting iron deficiency over haemoglobin
concentration alone. This added value applied both to
ZPP measured in whole blood or erythrocytes. By con-
trast, we found that the diagnostic performance of haemo-
globin concentration in detecting iron deficiency was
similar in pregnant women (AUC: 61%, [4]) as in children
(AUC: 63%, present study); in pregnant women, however,
replacement of haemoglobin concentration by ZPP, or
addition by ZPP to haemoglobin concentration, whether
measured in whole blood or in erythrocytes, had little
diagnostic value [4].
When combined with haemoglobin concentration,
whole blood ZPP or erythrocyte ZPP yielded AUC values
for the ROC curves of approximately 84%. Whether this
accuracy is satisfactory depends on the purpose of
testing. Conventional cut-off points for whole blood ZPP
and erythrocyte ZPP are clearly inappropriate and
produce gross overestimates of prevalence and a very
low positive predictive value (Table 5 in this paper; see
also [4]) due to their low specificity. Mwangi et al. 2014
[4], reported how cut-off points can be manipulated to
minimize bias in the estimation of population preva-
lence. In the present paper, we have shown how cut-
off points for haemoglobin and whole blood ZPP,
either alone or in combination, can be calibrated in a
screen-and-treat strategy to identify individuals with
iron deficiency at community level. Screening gener-
ally requires the selection of a cut-off point to ensure
a high sensitivity for the test or combination of tests
to be employed. Such high sensitivity ensures that
most cases are detected, at the cost of false positives
that can be eliminated by further diagnostic tests.
Although the accuracy of this approach is insufficient
to give a final diagnosis in all individuals, the
combination of haemoglobin concentration and
whole blood ZPP can constitute a rapid and
convenient method to rule out iron deficiency in a
substantial proportion of children screened. Although
we considered the example of screening at commu-
nity level, a similar strategy can be employed in clin-
ical practice to identify children who may need
referral to higher levels of care for further testing.
When 0.07195[Hb] + 0.01449[ZZPwhole] < 10.39334,
the diagnostic accuracy may be improved by using a com-
bination of erythrocyte ZPP with haemoglobin concentra-
tion, but the improved diagnostic accuracy thus achieved
must be weighed against the procedure of washing red
cells, which may be cumbersome in practice.
One problem that has not been solved in our study is
the difficulty in detecting iron deficiency in the presence
of inflammation. The associations found between ZPP
and Plasmodium infection and between ZPP and C-
reactive protein, underscore the importance of this issue.
Further research is required to extend and validate our
approach with appropriately selected reference standard
for iron deficiency in a population that included individ-
uals with inflammation and infections. Because point-of-
care tests are rapidly developing, with quantitative tests
already being commercially available for plasma concen-
trations of ferritin and C-reactive protein, and for
various infections, this is likely to be a fruitful area of
future research.
Conclusion
In Kenyan preschool children, ZPP, whether measured in
whole blood or in erythrocytes, has added diagnostic
value in detecting iron deficiency over haemoglobin
concentration alone. When used in a screen-and-treat
approach, combination of haemoglobin concentration
and whole blood ZPP in a single diagnostic score can be
used as a rapid and convenient testing method to rule
out iron deficiency in a substantial proportion of
children screened.
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